BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 2584352)

  • 1. Insulin-like growth factor-II in nonislet cell tumors associated with hypoglycemia: increased levels of messenger ribonucleic acid.
    Lowe WL; Roberts CT; LeRoith D; Rojeski MT; Merimee TJ; Fui ST; Keen H; Arnold D; Mersey J; Gluzman S
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1153-9. PubMed ID: 2584352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased insulin-like growth factor II production and consequent suppression of growth hormone secretion: a dual mechanism for tumor-induced hypoglycemia.
    Ron D; Powers AC; Pandian MR; Godine JE; Axelrod L
    J Clin Endocrinol Metab; 1989 Apr; 68(4):701-6. PubMed ID: 2646313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of somatomedin/insulin-like growth factor messenger ribonucleic acids in the human fetus: identification, characterization, and tissue distribution.
    Han VK; Lund PK; Lee DC; D'Ercole AJ
    J Clin Endocrinol Metab; 1988 Feb; 66(2):422-9. PubMed ID: 2448331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone dependence of somatomedin-C/insulin-like growth factor-I and insulin-like growth factor-II messenger ribonucleic acids.
    Hynes MA; Van Wyk JJ; Brooks PJ; D'Ercole AJ; Jansen M; Lund PK
    Mol Endocrinol; 1987 Mar; 1(3):233-42. PubMed ID: 3453890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced levels of insulin-like growth factor messenger RNA in human colon carcinomas and liposarcomas.
    Tricoli JV; Rall LB; Karakousis CP; Herrera L; Petrelli NJ; Bell GI; Shows TB
    Cancer Res; 1986 Dec; 46(12 Pt 1):6169-73. PubMed ID: 3779638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormalities of insulin-like growth factor (IGF-I and IGF-II) genes in human tumor tissue.
    Schneid H; Seurin D; Noguiez P; Le Bouc Y
    Growth Regul; 1992 Mar; 2(1):45-54. PubMed ID: 1362510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-like growth factor II mRNA expression in human breast cancer.
    Yee D; Cullen KJ; Paik S; Perdue JF; Hampton B; Schwartz A; Lippman ME; Rosen N
    Cancer Res; 1988 Dec; 48(23):6691-6. PubMed ID: 3180080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
    Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
    J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-like growth factor II messenger ribonucleic acid expression in Wilms tumor, nephrogenic rest, and kidney.
    Yun K; Molenaar AJ; Fiedler AM; Mark AJ; Eccles MR; Becroft DM; Reeve AE
    Lab Invest; 1993 Nov; 69(5):603-15. PubMed ID: 7504120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor family in malignant haemangiopericytomas: the expression and role of insulin-like growth factor I receptor.
    Pavelić K; Pavelić ZP; Cabrijan T; Karner I; Samarzija M; Stambrook PJ
    J Pathol; 1999 May; 188(1):69-75. PubMed ID: 10398143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of growth hormone treatment on the insulin-like growth factor axis in a child with nonislet cell tumor hypoglycemia.
    Katz LE; Liu F; Baker B; Agus MS; Nunn SE; Hintz RL; Cohen P
    J Clin Endocrinol Metab; 1996 Mar; 81(3):1141-6. PubMed ID: 8772589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the insulin-like growth factors and their binding proteins by glucocorticoid and growth hormone in nonislet cell tumor hypoglycemia.
    Baxter RC; Holman SR; Corbould A; Stranks S; Ho PJ; Braund W
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2700-8. PubMed ID: 7545698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: autocrine growth stimulation by IGF-II via the IGF-I receptor.
    Raile K; Höflich A; Kessler U; Yang Y; Pfuender M; Blum WF; Kolb H; Schwarz HP; Kiess W
    J Cell Physiol; 1994 Jun; 159(3):531-41. PubMed ID: 8188767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the IGF system and analysis of the possible molecular mechanisms leading to IGF-II overexpression in a mesothelioma.
    Hodzic D; Delacroix L; Willemsen P; Bensbaho K; Collette J; Broux R; Lefèbvre P; Legros JJ; Grooteclaes M; Winkler R
    Horm Metab Res; 1997 Nov; 29(11):549-55. PubMed ID: 9479554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and secretion of insulin-like growth factor II by a leiomyosarcoma with associated hypoglycemia.
    Daughaday WH; Emanuele MA; Brooks MH; Barbato AL; Kapadia M; Rotwein P
    N Engl J Med; 1988 Dec; 319(22):1434-40. PubMed ID: 3185662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II.
    Shapiro ET; Bell GI; Polonsky KS; Rubenstein AH; Kew MC; Tager HS
    J Clin Invest; 1990 May; 85(5):1672-9. PubMed ID: 2159026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor axis abnormalities in prostatic stromal cells from patients with benign prostatic hyperplasia.
    Cohen P; Peehl DM; Baker B; Liu F; Hintz RL; Rosenfeld RG
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1410-5. PubMed ID: 7525636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of insulin-like growth factor II mRNA in human primary liver cancers, benign liver tumors, and liver cirrhosis.
    Cariani E; Lasserre C; Seurin D; Hamelin B; Kemeny F; Franco D; Czech MP; Ullrich A; Brechot C
    Cancer Res; 1988 Dec; 48(23):6844-9. PubMed ID: 3180092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factors (IGFs) and their receptors in adrenal tumors: high IGF-II expression in functional adrenocortical carcinomas.
    Ilvesmäki V; Kahri AI; Miettinen PJ; Voutilainen R
    J Clin Endocrinol Metab; 1993 Sep; 77(3):852-8. PubMed ID: 8370710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not.
    Okazaki R; Conover CA; Harris SA; Spelsberg TC; Riggs BL
    J Bone Miner Res; 1995 May; 10(5):788-95. PubMed ID: 7639114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.